Lyka Labs Limited (NSE:LYKALABS)
74.50
+1.18 (1.61%)
Jan 28, 2026, 12:48 PM IST
Lyka Labs Market Cap
Lyka Labs has a market cap or net worth of 2.62 billion as of January 27, 2026. Its market cap has decreased by -53.96% in one year.
Market Cap
2.62B
Enterprise Value
2.92B
Revenue
1.33B
Ranking
n/a
PE Ratio
133.76
Stock Price
74.50
Market Cap Chart
Since October 1, 2003, Lyka Labs's market cap has increased from 294.62M to 2.62B, an increase of 788.18%. That is a compound annual growth rate of 10.27%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jan 27, 2026 | 2.62B | -3.39% |
| Dec 31, 2025 | 2.71B | -51.91% |
| Dec 31, 2024 | 5.63B | 37.55% |
| Dec 29, 2023 | 4.09B | 10.05% |
| Dec 30, 2022 | 3.72B | -41.66% |
| Dec 31, 2021 | 6.38B | 617.10% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Biocon | 592.65B |
| Anthem Biosciences | 341.96B |
| OneSource Specialty Pharma | 164.13B |
| Concord Biotech | 130.55B |
| Blue Jet Healthcare | 75.02B |
| Supriya Lifescience | 57.63B |
| Zota Health Care | 40.27B |
| Dishman Carbogen Amcis | 32.82B |